"DMC Sinai-Grace Hospital draws on the traditions of two community hospitals and combines that history with the strength of a large medical system - The Detroit Medical Center (DMC). The hospital today continues to have deep roots in the community, providing compassionate, personal care backed by advanced medical treatments available locally and throughout the DMC."

During the past decade, Sinai-Grace Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 14 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 9 clinical trials were completed. i.e. 112.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sinai-Grace Hospital" #1 sponsor was "Neuren Pharmaceuticals Limited" with 2 trials, followed by "University of Virginia" with 2 trials sponsored, "Wayne State University" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Amgen" with 1 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sinai-Grace Hospital" #1 collaborator was "Medical University of South Carolina" with 9 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 7 trials as a collaborator, "Neurological Emergencies Treatment Trials Network (NETT)" with 5 trials as a collaborator, "University of Michigan" with 3 trials as a collaborator and "Johns Hopkins University" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Sinai-Grace Hospital" are "Sepsis" (3 trials), "Brain Injuries" (2 trials), "COVID-19" (2 trials), "Heart Failure" (2 trials) and "Hyperglycemia" (2 trials). Many other conditions were trialed in "Sinai-Grace Hospital" in a lesser frequency.

Most popular intervention types in "Sinai-Grace Hospital" are "Drug" (19 trials), "Device" (5 trials), "Procedure" (4 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "NNZ-2566" (2 trials), "Saline" (2 trials), "ART-123" (1 trials) and "Albumin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sinai-Grace Hospital" are 31 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Sinai-Grace Hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Sinai-Grace Hospital, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Sinai-Grace Hospital, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".